Issued 2026-09-16 at $199.46 · now $199.46 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, CTAS has typically landed between $182.41 and $219.29 — a range of −8.6% to +9.9% from the issuance price $199.46.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,685 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($199.46) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where CTAS has typically landed a month from the 2026-09-16 close of $199.46 — the range is history, not a prediction.
- now $199.46 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $203.16 (+1.9%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $195.53–$210.8
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $182.41–$219.29
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-21 | −46.4% | −46.4% | +0.0% |
| 2020-03-04 | −42.3% | −45.1% | +0.0% |
| 2020-02-20 | −41.2% | −41.2% | +0.0% |
| 3 best | |||
| 2009-03-06 | +38.2% | −1.6% | +39.8% |
| 2009-03-05 | +37.7% | −2.2% | +39.1% |
| 2020-05-07 | +36.6% | −6.5% | +36.6% |
4,685 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked
Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.
Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.
iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 74 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.- DCF (intrinsic)$145.44
- Peer P/E × EPS · sector median 30.7× · n=74$150.51
- Analyst target · range $214.00–$250.00$230.50
- Current price · last close 2026-09-16$199.46
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-22 | TYSOE RONALD W | director | Sale | 4,363 @ $199.90 | $872K | −16.3% of holding | −1.0% | not yet — horizon still open | 22,448 | Form 4 · filed 1 day after the trade |
| 2026-07-16 | Barstad Melanie W. | director | Sale | 9,142 @ $202.94 | $1.9M | −25.6% of holding | −6.7% | not yet — horizon still open | 26,592 | Form 4 · filed 4 days after the trade |
| 2026-04-20 | TYSOE RONALD W | director | Sale | 4,666 @ $178.87 | $835K | −17.2% of holding | −6.9% | not yet — horizon still open | 22,448 | Form 4 · filed 2 days after the trade |
| 2025-07-30 | TYSOE RONALD W | director | Sale | 5,084 @ $223.47 | $1.1M | −18.8% of holding | −8.7% | −24.6% | 21,945 | Form 4 · filed 2 days after the trade |
| 2025-07-28 | Schneider Todd M. | director | Sale | 17,301 @ $220.90 | $3.8M | −2.7% of holding | −4.5% | −22.7% | 622,712 | Form 4 · filed 1 day after the trade |
| 2025-07-21 | MUCCI MARTIN | director | Purchase | 1,200 @ $222.55 | $267K | +84.4% of holding | −3.8% | −20.5% | 2,621 | Form 4 · filed 2 days after the trade |
| 2025-04-14 | TYSOE RONALD W | director | Sale | 8,521 @ $208.96 | $1.8M | −24.0% of holding | −6.8% | −33.4% | 27,029 | Form 4 · filed 2 days after the trade |
| 2025-04-07 | Rozakis Jim | officer | Sale | 2,000 @ $190.37 | $381K | −0.8% of holding | +1.6% | −28.5% | 256,528 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
292 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Schneider Todd M. | director | Award / grant | 57,944 | 727,006 | Form 4 |
| 2026-08-10 | Schneider Todd M. | director | Withheld for tax | 35,599 | 691,407 | Form 4 |
| 2026-08-10 | FARMER SCOTT D | director | Withheld for tax | 15,923 | 87,899 | Form 4 |
| 2026-08-10 | Rozakis Jim | officer | Award / grant | 10,695 | 285,808 | Form 4 |
| 2026-08-10 | Garula Scott | officer | Award / grant | 10,695 | 108,453 | Form 4 |
| 2026-08-10 | Denton David Brock | officer | Award / grant | 5,348 | 31,205 | Form 4 |
| 2026-08-10 | Rozakis Jim | officer | Withheld for tax | 3,643 | 282,720 | Form 4 |
| 2026-08-10 | Denton David Brock | officer | Withheld for tax | 3,479 | 28,096 | Form 4 |
| 2026-08-10 | Garula Scott | officer | Withheld for tax | 2,958 | 105,495 | Form 4 |
| 2026-08-10 | FARMER SCOTT D | director | Award / grant | 830 | 103,822 | Form 4 |
| 2026-08-10 | Rozakis Jim | officer | Award / grant | 555 | 286,363 | Form 4 |
| 2026-08-10 | Denton David Brock | officer | Award / grant | 370 | 31,575 | Form 4 |
| 2026-08-10 | Rozakis Jim | officer | Award / grant | 5,988 | 5,988 | Form 4 |
| 2026-08-10 | Rozakis Jim | officer | Award / grant | 35,995 | 35,995 | Form 4 |
| 2026-08-10 | Denton David Brock | officer | Award / grant | 17,999 | 17,999 | Form 4 |
| 2026-08-10 | Denton David Brock | officer | Award / grant | 4,435 | 4,435 | Form 4 |
| 2026-07-28 | Barstad Melanie W. | director | Award / grant | 148 | 4,734 | Form 4 |
| 2026-07-28 | CARNAHAN KAREN L | director | Award / grant | 134 | 6,816 | Form 4 |
| 2026-07-28 | Coletti Robert E. | director | Award / grant | 116 | 11,363 | Form 4 |
| 2026-07-22 | TYSOE RONALD W | director | Withheld for tax | 685 | 26,811 | Form 4 |
| 2026-07-22 | TYSOE RONALD W | director | Option exercise | 5,048 | 27,496 | Form 4 |
| 2026-07-22 | TYSOE RONALD W | director | Option exercise | 5,048 | 0 | Form 4 |
| 2026-07-16 | Barstad Melanie W. | director | Withheld for tax | 1,406 | 35,734 | Form 4 |
| 2026-07-16 | Barstad Melanie W. | director | Option exercise | 10,548 | 37,140 | Form 4 |
| 2026-07-16 | Barstad Melanie W. | director | Option exercise | 10,548 | 0 | Form 4 |
| 2026-07-01 | Garula Scott | officer | Withheld for tax | 249 | 97,758 | Form 4 |
| 2026-06-15 | TYSOE RONALD W | director | Award / grant | 100 | 38,839 | Form 4 |
| 2026-06-15 | Coletti Robert E. | director | Award / grant | 29 | 11,247 | Form 4 |
| 2026-06-15 | CARNAHAN KAREN L | director | Award / grant | 17 | 6,682 | Form 4 |
| 2026-06-15 | Barstad Melanie W. | director | Award / grant | 12 | 4,586 | Form 4 |
| 2026-04-20 | TYSOE RONALD W | director | Withheld for tax | 834 | 27,114 | Form 4 |
| 2026-04-20 | TYSOE RONALD W | director | Option exercise | 5,500 | 27,948 | Form 4 |
| 2026-04-20 | TYSOE RONALD W | director | Option exercise | 5,500 | 5,048 | Form 4 |
| 2026-04-14 | Barstad Melanie W. | director | Award / grant | 181 | 4,574 | Form 4 |
| 2026-04-14 | CARNAHAN KAREN L | director | Award / grant | 163 | 6,665 | Form 4 |
| 2026-04-14 | Coletti Robert E. | director | Award / grant | 142 | 11,218 | Form 4 |
| 2026-04-09 | Coletti Robert E. | director | Option exercise | 10,548 | 26,744 | Form 4 |
| 2026-04-09 | Coletti Robert E. | director | Option exercise | 1,996 | 16,196 | Form 4 |
| 2026-04-09 | Coletti Robert E. | director | Option exercise | 1,996 | 0 | Form 4 |
| 2026-04-09 | Coletti Robert E. | director | Option exercise | 10,548 | 0 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.
As of 2026-09-16 · point-in-time by filed date
A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).
| Member | Chamber | Type | Filed | Traded | Size |
|---|---|---|---|---|---|
| Ro Khanna | House | sale | 2026-07-06 | 2026-06-30 | $1–15K |
| Ro Khanna | House | purchase | 2026-07-06 | 2026-06-02 | $1–15K |
| Ro Khanna | House | purchase | 2026-07-06 | 2026-06-16 | $1–15K |
| Ro Khanna | House | purchase | 2026-06-09 | 2026-05-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-05-11 | 2026-04-24 | $1–15K |
| Ro Khanna | House | sale | 2026-04-07 | 2026-03-23 | $1–15K |
| Ro Khanna | House | sale | 2026-04-07 | 2026-03-30 | $1–15K |
| Ro Khanna | House | purchase | 2026-02-06 | 2026-01-13 | $1–15K |
| Ro Khanna | House | sale | 2026-02-06 | 2026-01-29 | $1–15K |
| Ro Khanna | House | sale | 2025-12-08 | 2025-11-10 | $1–15K |
| Ro Khanna | House | sale | 2025-12-08 | 2025-11-03 | $1–15K |
| Lisa Mcclain | House | sale | 2025-10-22 | 2025-09-11 | $1–15K |
| Valerie Hoyle | House | sale | 2025-10-10 | 2025-09-23 | $1–15K |
| Ro Khanna | House | sale | 2025-10-03 | 2025-09-05 | $1–15K |
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.